Susquehanna International Group’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Susquehanna International Group’s Portfolio KRBP Stock Details KRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,203	Closed	-$55K	–	14372
2021 Q4	$55K	Buy	1,203 +200	+20%	+$13.6K	﹤0.01%	12504
2021 Q3	$92K	Buy	+1,003	New	+$104K	﹤0.01%	12108

Other funds holding KRBP

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group's KRBP Position: Q2 2023 in Review

Susquehanna International Group sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q2 2023, closing a stake of 16,457 shares — an estimated $64.2K sold.

Susquehanna International Group first reported a position in KRBP in Q4 2021 and held it in 3 quarters. The position peaked at $64.2K in Q1 2023. 5 funds tracked by Wall St. Rank hold KRBP as of Q2 2023.

Susquehanna International Group reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 16,457 Kiromic BioPharma, Inc. Common Stock shares in Q2 2023, an estimated $64.2K.
Susquehanna International Group first reported a position in Kiromic BioPharma, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Susquehanna International Group's Kiromic BioPharma, Inc. Common Stock position peaked at $64.2K in Q1 2023.
5 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.